LumiraDx (LumiraDx) Marketable Securities : $0.0 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. LumiraDx's Marketable Securities for the quarter that ended in Jun. 2023 was $0.0 Mil.

LumiraDx Marketable Securities Historical Data

The historical data trend for LumiraDx's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Marketable Securities Chart

LumiraDx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Marketable Securities

LumiraDx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Marketable Securities	Get a 7-Day Free Trial								-	-	-	-	-

LumiraDx Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

LumiraDx (OTCPK:LMDXF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

LumiraDx Marketable Securities Related Terms

Thank you for viewing the detailed overview of LumiraDx's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

LumiraDx (LumiraDx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDXF) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108

Website

https://www.lumiradx.com

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.